How is Rosai-Dorfman disease diagnosed?

TL;DR: Diagnosing Rosai-Dorfman disease primarily requires a surgical biopsy of affected tissue to confirm the presence of characteristic histiocytes exhibiting "emperipolesis" under microscopic examination. Because Rosai-Dorfman disease is a rare histiocytic disorder that can mimic lymphoma or other inflammatory conditions, definitive diagnosis often requires specialized pathology review and correlation with clinical and imaging findings.

How is a diagnosis of Rosai-Dorfman disease confirmed?

The diagnostic journey for Rosai-Dorfman disease is often lengthy because the condition is rare and can present in almost any organ system, most commonly as painless, massive lymph node enlargement in the neck (cervical lymphadenopathy). Because there is no single blood test to identify it, the gold standard for diagnosis is a biopsy. A pathologist must examine the tissue to identify large, distinctive histiocytes that contain intact lymphocytes and other inflammatory cells within their cytoplasm—a phenomenon known as emperipolesis. Immunohistochemical staining is then used to confirm the cells are S100-positive and CD68-positive, which helps distinguish Rosai-Dorfman disease from other histiocytic disorders.

What tests are involved in the diagnostic process?

Once a physician suspects Rosai-Dorfman disease, they will typically order a series of investigations to determine the extent of the disease and rule out other conditions. The diagnostic workup usually includes:

• Surgical Biopsy: The definitive step, where a whole lymph node or tissue sample is removed for expert histopathological analysis.


• Imaging (PET/CT or MRI): Used to map the full extent of the disease, as Rosai-Dorfman disease can manifest in extranodal sites like the skin, eyes, central nervous system, or bone.


• Blood Panels: While not diagnostic, doctors often check complete blood counts (CBC), inflammatory markers (like ESR or CRP), and IgG levels to assess the systemic impact.


• Genetic Testing: Recent research has identified somatic mutations in the MAPK pathway (such as KRAS, MAP2K1, or BRAF) in a subset of patients, which can help confirm the diagnosis and guide potential targeted therapy.

Why is the diagnostic odyssey so challenging?

Many of the 16 members in our DiseaseMaps.org community have shared the frustration of a long "diagnostic odyssey." Because Rosai-Dorfman disease is rare, it is frequently misdiagnosed initially as lymphoma, tuberculosis, or sarcoidosis. The lack of awareness among primary care providers means patients often visit multiple specialists—including hematologists, oncologists, and rheumatologists—before a pathologist with expertise in histiocytic disorders is consulted. This delay is not a reflection of your medical history, but a symptom of the disease's rarity and clinical complexity.

Which specialists should be involved in my care?

If you suspect you have Rosai-Dorfman disease, it is vital to be managed by a multidisciplinary team. A hematologist-oncologist or a pathologist specializing in hematopoietic or histiocytic disorders should lead the diagnostic evaluation. Because the disease can affect various organs, you may also require consultations with an ophthalmologist, neurologist, or dermatologist, depending on where the disease is located. Seeking an opinion at a major academic medical center or a specialized rare disease center is highly recommended to ensure the biopsy findings are accurately interpreted.

Next steps

• Request a Pathology Review: Ask your local hospital to send your biopsy slides to a major research center for a second opinion from a hematopathologist.


• Find a Specialist: Consult with a hematologist-oncologist who has specific clinical experience with histiocytic disorders.


• Connect with Community: Join the Rosai-Dorfman disease group on DiseaseMaps.org to share experiences and learn from others who have navigated the diagnostic process.


• Keep Records: Request copies of your pathology reports, imaging discs, and biopsy results to carry with you to all specialist appointments.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: "Rosai-Dorfman disease" (ORPHA:3125)


• NIH GARD: "Rosai-Dorfman disease" (Genetic and Rare Diseases Information Center)


• OMIM: Online Mendelian Inheritance in Man, "Rosai-Dorfman Disease" (Entry #619561)


• Histiocyte Society: Clinical guidelines for the diagnosis and management of histiocytic disorders.